Doxepin and amitriptyline-perphenazine in mixed anxious-depressed neurotic outpatients: a collaborative controlled study.
D000328:Adult; D000639:Amitriptyline / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D003990:Dibenzoxepins / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy*; D010546:Perphenazine / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011153:Population; D011593:Psychology, Social; D012959:Socioeconomic Factors; D013223:Statistics as Topic
D003990:Dibenzoxepins; D004338:Drug Combinations; D010919:Placebos; D000639:Amitriptyline; D010546:Perphenazine